Patients with severe acute-on-chronic liver failure are disadvantaged by model for end-stage liver disease-based organ allocation policy.
Vinay SundaramParth ShahNadim MahmudChristina C LindenmeyerAndrew S KleinRobert J WongConstantine J KarvellasSumeet K AsraniRajiv JalanPublished in: Alimentary pharmacology & therapeutics (2020)
The MELD-Na score disadvantages patients with ACLF-3, both with and without extra-hepatic organ failures. Incorporation of organ failures into allocation policy warrants further exploration.